ALDX

ADX-2191 (DHFR inhibitor)

Proliferative Vitreoretinopathy

Phase 3 to be initiated

Exp Date

2021

Amp Volatility Score

N/A

Catalyst Info & Data Links

TITLE:  ADX-2191 for Proliferative Vitreoretinopathy Phase 3 to be initiated

  • Clinical Trial (NCT04136366) The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy


WHAT IS THE NEXT CATALYST EVENT?

  • Phase 3 to be initiated


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • 2021


PRIOR DATA/EVENTS

PRESS RELEASES

MECHANISM OF ACTION

  • Dihydrofolate reductase (DHFR) is an enzyme involved in cellular replication and activation. Methotrexate, the active component of ADX-2191, is a DHFR inhibitor, which has been used to treat cancer and autoimmune disease. The anti-proliferative and anti-inflammatory properties of DHFR inhibition are well described.

  • Proliferative vitreoretinopathy (PVR) is characterized by excessive replication and pro-inflammatory activity of retinal cells, at least a portion of which synthesize collagen, the principal component of scar tissue. Retinal scarring can lead to impairment of vision, including blindness. In preclinical studies of primary cell cultures from PVR patients, DHFR inhibition reduced pathological cell proliferation and scar-like collagen deposition. The observed clinical activity of our investigational new drug ADX-2191 in PVR is believed to be the result of the down-regulation of aberrant retinal cell proliferation and activity, thereby leading to reduced retinal scarring.

  • Source 

Updated by MV

Proliferative vitreoretinopathy, eye disease, VP, DHFR, ADX-2191, ALDX, Aldeyra

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon